We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Provexis Plc (PXS) Ordinary 0.1p

Sell:0.50p Buy:0.60p 0 Change: 0.05p (8.33%)
Market closed Prices as at close on 19 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.50p
Buy:0.60p
Change: 0.05p (8.33%)
Market closed Prices as at close on 19 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.50p
Buy:0.60p
Change: 0.05p (8.33%)
Market closed Prices as at close on 19 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Provexis plc is engaged in developing, licensing and selling the proprietary, scientifically proven Fruitflow heart-health functional food ingredient. Fruitflow is a natural extract from tomatoes, which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available in two formats, a syrup and a spray-dried powder and can be included in a range of food, beverage, and dietary supplement formats. Fruitflow is a highly concentrated form of bioactives that is lycopene-free and contains over 30 known anti-platelet compounds. The syrup and powder versions of Fruitflow are GRAS in the United States. The Company also offers Fruitflow+ Omega-3, a dietary supplement product. The Company sells its Fruitflow+ Omega-3 dietary supplement product direct to consumers and serves its Chinese cross-border e-commerce distributor for this product in China.

Contact details

Address:
2 Blagrave Street
READING
RG1 1AZ
United Kingdom
Telephone:
+44 (01753) 861777
Website:
https://www.provexis.com/

Important dates

Future events
There are no future events available.
Past events
AGM 26 October 2023 26/10/23

General stock information

EPIC:
PXS
ISIN:
GB00B0923P27
Market cap:
£12.45 million
Shares in issue:
2.26 billion
Sector:
Food Producers
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Ian Ford
    Chief Executive Officer, Executive Director, Company Secretary
  • Niamh O'kennedy
    Chief Scientific Officer, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.